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Note
The Post-Grant Problem: America Invents Falling
Short
Kayla Fossen*
INTRODUCTION
Prior to the passage of the Leahy-Smith America Invents
Act (AIA), the United States operated a patent system that was
in many ways unique among developed nations. For example,
priority was determined by the first applicant to invent the
process or item in question,1 an applicant had to disclose the
“best mode” for practicing the claimed invention,2 and the process for review of a patent after issuance was extremely limited.3 Additionally, the patent prosecution system in the United
States was a slow, inefficient process.4 Patents were frequently
invalidated, and those that were not invalidated required an
inordinate amount of time and resources to defend.5 In an attempt to address these issues, Congress passed AIA.6 Under
the new system many of the differences between the U.S. patent system and the European patent system have been har-

© 2013 Kayla Fossen
* J.D. Candidate, 2013, University of Minnesota Law School. The author would like to thank Professor Ruth Okediji, Professor Thomas Cotter, and
Brad Pedersen for their inspiration and expertise and the editors and staff of
the journal for all their hard work.
1. H.R. REP. NO. 112-98, pt. 1, at 40 (2011).
2. 35 U.S.C. § 112 (2006); United States Patent and Trademark OFFICE,
MANUAL OF PATENT EXAMINATION PROCEDURE §§ 2138.01 pt. I, 2165 (8th ed.
2010) [hereinafter MPEP].
3. See JANICE M. MUELLER, AN INTRODUCTION TO PATENT LAW 256–57
(2d ed. 2006).
4. See generally NAT’L RESEARCH COUNCIL, A PATENT SYSTEM FOR THE
21ST CENTURY 1–2 (Stephen A. Merrill et al. eds., 2004) (identifying weaknesses in the current U.S. patent system and proposing methods for improving
the system).
5. Id. at 4.
6. H.R. REP. NO. 112-98, pt.1, at 38–40.
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monized,7 a new post-grant review process has been established,8 and the ability of third parties to participate has been
significantly increased.9 It has yet to be determined, however,
whether these changes will effectively promote the goals established by Congress.
The goal of this Note is to determine whether the new postgrant system established under AIA will ameliorate those issues identified by Congress as problematic within the current
patent regime. Part I of this Note will describe the current international framework for patents as established by the
Agreement on Trade-Related Aspects of Intellectual Property
Rights (TRIPS), the current United States patent regime, the
current European patent regime, and the changes to the U.S.
patent regime made by AIA. Part II compares the changes
made by AIA—in particular changes regarding the new postgrant review—to the European system they are modeled after.
Part III identifies failures and proposes a more selective pregrant review system to address the failures. This Note concludes that, while the new patent regime created by AIA takes
important steps towards addressing patent strength and litigation issues, under the current legal system a more stringent
pre-grant review is necessary to meet the goals of AIA.
II. BACKGROUND
A. TRIPS: THE INTERNATIONAL FRAMEWORK FOR DOMESTIC
PATENT LAW
Patent law in all World Trade Organization (WTO) countries, including the United States, is governed by TRIPS.10
Signed in 1994, TRIPS attempts to harmonize intellectual
property protection in order to promote free trade among mem-

7. Id. at 39.
8. Id. at 45.
9. Id. at 45–46.
10. Agreement on Trade-Related Aspects of Intellectual Property Rights,
Apr. 14, 1994, 1869 U.N.T.S. 299 [hereinafter TRIPS]; Frequently Asked QuesTRADE
ORG.,
tions
About
TRIPS
in
the
WTO,
WORLD
http://www.wto.org/english/tratop_e/trips_e/tripfq_e.htm (last visited Oct. 3,
2012). There are 157 member nations, including all major developed nations.
Members and Observers, WORLD TRADE ORG., http://www.wto.org/english/
thewto_e/whatis_e/tif_e/org6_e.htm (last visited Oct. 3, 2012).
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ber nations.11 TRIPS encompasses not only patents, but also
copyrights, trademarks, geographical indications, industrial
designs, topographies of integrated circuits, trade secrets, and
anti-competitive behaviors.12 Prior to TRIPS, international patent law harmonization was governed by the Paris Convention
for the Protection of Industrial Arts of 1967 (ParC).13 ParC was
so widely accepted as a model that large portions of it are incorporated by reference into TRIPS.14 Between ParC and
TRIPS, standards for patent regimes have been established.
These standards range from time frames for protections (not
less than twenty years from filing)15 to rights conferred.16 Some
standards include:
• The same rights must be granted to foreigners as citizens.17
• The filing date of a domestic patent application in one
country will be the effective date for patent applications
filed in all other countries, provided that subsequent applications are filed within the grace period.18
• With limited exceptions, individual technologies cannot
be discriminated against.19
• Exclusive use rights are granted, though compulsory licensing may be required by granting countries.20
• The invention must be disclosed in a manner that would
enable a person skilled in the art to practice the invention;21 and
• “An opportunity for judicial review of any decision to re-

11. NUNO PIRES DE CARVALHO, THE TRIPS REGIME OF PATENT RIGHTS 40
(2d ed. 2005).
12. Id. at 29.
13. Paris Convention for the Protection of Industrial Property, July 14,
1967, 21 U.S.T. 1583 [hereinafter ParC].
14. TRIPS, supra note 10, at art. 2.
15. Id. at art. 33.
16. Id. at art. 28.
17. Id. at art. 1.
18. ParC, supra note 13, at art. 4.
19. TRIPS, supra note 10, at art. 27; PIRES DE CARVALHO, supra note 11,
at 167.
20. TRIPS, supra note 10, at arts. 28, 30; ParC, supra note 13, at art. 5;
Intellectual Property: Protection and Enforcement, WORLD TRADE ORG.,
http://www.wto.org/english/thewto_e/whatis_e/tif_e/agrm7_e.htm (last visited
Oct. 3, 2012).
21. TRIPS, supra note 10, at art. 29.
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voke or forfeit a patent shall be available.”22
There is no initial procedure or required reason prescribed
for revocation, so any revocation is at the discretion of the patent-granting states.23 The requirement for judicial appeal and
a lack of direction as to what form this appeal must take have
led to a wide range of mechanisms for challenging patents and
appealing those decisions. For example, the United States uses
a reexamination process in addition to federal litigation, while
Europe uses a post-grant opposition system.24
B. RE-ISSUE, REEXAMINE: THE CURRENT U.S. PATENT REGIME
In the United States the federal government is granted the
power to issue patents for the promotion of the “[p]rogress of
Science and useful Arts” by the U.S. Constitution.25 As a reward for investment and public disclosure an inventor is granted a limited monopoly for the claimed invention for a period of
time, typically twenty years from the date the application was
filed.26 An invention could be a “process, machine, manufacture, or composition of matter.”27 There are, however, certain
classes of inventions that cannot be patented, including laws of
nature (e.g. gravity), natural phenomena (e.g. naturally occurring minerals), and abstract ideas (e.g. mathematical algorithms).28
The process for obtaining a patent is a long one, on average
taking up to three years to obtain a single patent.29 Additionally, the granting of a patent is not guaranteed. In order to obtain
a patent the inventor must apply, and the invention must meet
some very basic requirements. The invention must be novel,
have utility, and must be a non-obvious improvement over any

22. Id. at art. 32.
23. PIRES DE CARVALHO, supra note 11, at 372–73.
24. MUELLER, supra note 3, at 256–57, 263.
25. U.S. CONST. art. I, § 8, cl. 8.
26. 35 U.S.C. § 154 (2006); Kevin R. Davidson, Retooling Patents: Current
Problems, Proposed Solutions, and Economic Implications for Patent Reform, 8
HOUS. BUS. & TAX L.J. 425, 428 (2008); see Kewanee Oil Co. v. Bicron Corp.,
416 U.S. 470, 480–81 (1974).
27. 35 U.S.C. § 101.
28. MPEP, supra note 2, at § 2106.
29. Mark A. Lemley, Patenting Nanotechnology, 58 STAN. L. REV. 601, 604
(2005).
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prior inventions (prior art).30 The process for obtaining a patent—patent prosecution—tends to follow a standard trajectory. First the inventor or his legal representative files a patent
application.31 The patent examiner then determines what the
inventor is trying to patent, whether it has utility, what relevant prior art exists, and if the invention claimed would not be
obvious to a person “skilled in the art” in light of the prior art.32
Even if all of these requirements are met, under the current
first-to-invent system, the applicant will not receive the patent
if there is another inventor who filed an application after, but
nevertheless invented before the applicant.33
After the patent is granted, the validity of the patent can
be challenged three different ways. First, the validity may be
challenged in federal court.34 When validity is challenged in
court there is a presumption that all issued patents are valid,
and in order to invalidate a patent the challenging party must
meet a “clear and convincing evidence” standard.35 Second, the
validity may be challenged in an ex parte reexamination proceeding.36 Anyone can request an ex parte reexamination, but
only the patent holder can participate in the proceedings.37 As a
result, there are no estoppel consequences for third parties if
the validity is challenged later in federal court, and the ruling
of the examiner cannot be appealed by third parties to the
United States Patent and Trademark Office’s (USPTO) Board
of Patent Appeals and Interferences (BPAI).38
30. 35 U.S.C. §§ 101, 103.
31. MUELLER, supra note 3, at 38.
32. MPEP, supra note 2, at § 2144.08.
33. H.R. REP. NO. 112-98, at 40 (2011); MPEP, supra note 2, at § 2138.01.
There are some limitations to this rule. Someone claiming to have invented
first who applied second must initiate an interference proceeding. MPEP, supra note 2, at § 2301. This second applicant must not have “abandoned, suppressed, or concealed” the invention. 35 U.S.C. § 102(g); MPEP, supra note 2,
at § 2138.03. An unreasonable delay in filing can be considered suppression or
concealment. MPEP, supra note 2, at § 2138.03; see Peeler v. Miller, 535 F.2d
647, 656 (C.C.P.A. 1976). Additionally, there must be reasonable diligence to
reduce the invention to practice and to file an application. MPEP, supra note
2, at § 2138.06.
34. MUELLER, supra note 3, at 32–36; see also Davidson, supra note 26, at
442–43.
35. MUELLER, supra note 3, at 364–65.
36. Id. at 258–62.
37. Id. at 258.
38. Compare id. at 258 (explaining the third-party requester’s level of participation in an ex parte reexamination), with id. at 263–64 (explaining the
procedure of inter partes reexamination, which includes the option for the
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Finally, the validity may be challenged in an inter partes
reexamination.39 In an inter partes reexamination, third parties
have an opportunity to participate in the arguments surrounding validity.40 As a result, third parties that participate are estopped from raising any question of invalidity that could have
been brought up at the reexamination proceedings, are allowed
to appeal any ruling first to the BPAI and then to the federal
circuit, and can request the court stay any federal litigation dependent on the validity of the patent until a decision is reached,
but the court need not grant it.41 In both ex parte and inter
partes reexaminations there must be a substantial new question of patentability based solely on published patents or printed publications, and only a preponderance of the evidence is required.42 Ex parte reexaminations are used rarely (roughly
0.2% of issued patents).43 Since its enactment in 1999, inter
partes reexaminations have been increasing, but there is no evidence that they will be used at a significantly higher rate than
ex parte reexaminations.44
Some minor changes were made to U.S. patent law as a result of signing onto TRIPS.45 Patent terms are now twenty
years from the date of filing, instead of seventeen years from
issuance.46 Foreign inventers are now allowed to use evidence
of practice or development in WTO countries to establish invention dates.47 The definition of infringement was expanded,48
third-party requester to appeal to the BPAI and is subject to the estoppel provision of 35 U.S.C. § 315(c) (2006)).
39. Id. at 263.
40. Id.
41. Id. at 263–65.
42. MPEP, supra note 2, at § 706.I; Sherry M. Knowles, Thomas E. Vanderbloemen & Charles E. Peeler, Inter Partes Patent Reexamination in the
United States, 86 J. PAT. & TRADEMARK OFF. SOC’Y 611, 611–12 (2004).
43. Dale L. Carlson & Robert A. Migliorini, Patent Reform at the Crossroads: Experience in the Far East with Oppositions Suggests an Alternative
Approach for the United States, 7 N.C. J.L. & TECH. 261, 269 (2006).
44. From 2006 through 2010, 973,368 patents were issued, and 903 inter
partes reexaminations were filed (~0.1%). U.S. PATENT AND TRADEMARK
OFFICE, PERFORMANCE AND ACCOUNTABILITY REPORT: FISCAL YEAR 2010, at
129, 137 [hereinafter ACCOUNTABILITY REPORT 2010].
45. See ROBERT P. MERGES & JOHN F. DUFFY, PATENT LAW AND POLICY:
CASES AND MATERIALS 58 (5th ed. 2011).
46. 35 U.S.C. § 154 (2006); MERGES & DUFFY, supra note 45, at 58.
47. 35 U.S.C. § 104; MERGES & DUFFY, supra note 45, at 58.
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and provisional applications were introduced.49 Despite these
attempts at global harmonization, major differences between
the United States and other national patent regimes still exist.
C. PATTERNING AFTER PATENT OPPOSITION: THE EUROPEAN
SYSTEM OF POST-GRANT REVIEW
European patents are governed by the European Patent
Convention (EPC),50 an agreement allowed by ParC.51 Under
the EPC, any patent granted by the European Patent Office
(EPO) is enforceable in any contracting country as if it were a
national patent.52 In order for a patent to be issued the invention must be “[novel], include an inventive step, and [be] susceptible [to] industrial application.”53 Like in U.S. patent law,
novelty is determined based on a comparison with only a single
piece of prior art, not a combination of multiple pieces.54 The
inventive step, like the non-obvious requirement in U.S. patent
law, should be determined based on the combination of all relevant prior art.55 European patent applications are published
the sooner of eighteen months after the filing date or eighteen
months after the priority date—a date prior to the filing that
the application claims is a better representation of when the
invention was originally claimed—and priority rules are based
on ParC and EPC rules.56 Third parties who feel they have important information regarding an application can submit information relevant to the patent proceedings during the application process in filings called “observations.”57 Once a patent
is issued, it is enforceable for twenty years from the filing
date.58 European patents are enforced at the national level.59

48. 35 U.S.C. § 271; MERGES & DUFFY, supra note 45, at 58
49. 35 U.S.C. § 111; MERGES & DUFFY, supra note 45, at 58.
50. European Patent Convention, Oct. 5, 1973, 13 I.L.M. 270 [hereinafter
EPC].
51. ParC, supra note 13, at art. 19; IAN MUIR ET AL., EUROPEAN PATENT
LAW: LAW AND PROCEDURE UNDER THE EPC AND PCT 2 (2d ed. 2002).
52. EPC, supra note 50, at art. 2; MUIR ET AL., supra note 51, at 2.
53. EPC, supra note 50, at art. 52.
54. Id. at art. 54; MUIR ET AL., supra note 51, at 177; see MPEP, supra
note 2, at § 2131.01.
55. EPC, supra note 50, at art. 56; MUIR ET AL., supra note 51, at 189; see
35 U.S.C. § 103 (2006); MPEP, supra note 2, at § 2141.
56. EPC, supra note 50, at arts. 87–89, 93.
57. Id. at art. 115.
58. Id. at art. 63.
59. See MUIR ET AL., supra note 51, at 131.
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Unlike the United States, Europe operates under a first-tofile system.60 This means, if two inventors claim the same invention in two different patent applications the first person
that constructively filed their application under the ParC, rather than the first to invent, will receive the patent.61 Also, unlike the United States, the EPC operates a post-grant patent
opposition system.62 The post-grant opposition must be filed
within nine months of the grant of the patent in question.63 It
can be filed by anyone other than the patent holder and is a
contentious proceeding between the patentee and the opposition party.64 In the United States reexaminations can only be
issued for substantial new questions of patentability based on
printed prior art, but the EPC opposition proceedings allow for
challenges based on a large number of factors including a lack
of novelty, a lack of inventive step, a lack of industrial application, a lack of adequate disclosure, an inadmissible amendment, or that the subject matter is not an invention or a patentable subject matter.65 Like the inter partes reexamination
in the United States, an opposition can stay an infringement
suit in any of the contracting nations.66 If a third party wishes
to intervene in an opposition they must file a notice of opposition statement, which lays out the grounds upon which the opposition is being requested and any evidence to support those
grounds.67 Three examiners, two of which must be new to the
patent in question, are assigned to each opposition.68 Unlike
the United States’ reexaminations, evidence can be admitted
beyond printed prior art.69 After evidence is submitted and oral
60. H.R. REP. NO. 112-98, at 40 (2011); Seth T. Carnathan, Patent Priority
Disputes—A Proposed Re-Definition of “First-to-Invent”, 49 ALA. L. REV. 755,
755–57 (1998).
61. Carnathan, supra note 60, at 757–58.
62. EPC, supra note 50, at art. 99.
63. Id.
64. MUIR ET AL., supra note 51, at 226–31.
65. EPC, supra note 50, at art. 100; MUIR ET AL., supra note 51, at 237.
Some countries, like Germany, allow for national level opposition proceedings.
Other countries, like the U.K., do not.
66. Carlson & Migliorini, supra note 43, at 276.
67. EPC, supra note 50, at art. 105; Carlson & Migliorini, supra note 43,
at 276.
68. Carlson & Migliorini, supra note 43, at 277.
69. Id. at 278; see 35 U.S.C. § 301 (2006); MPEP, supra note 2, at § 2205.
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arguments are heard, the court will render a decision and revoke the patent, reject the opposition, or allow the patent to
continue.70 The result is binding on all EPC countries.71 Either
party can appeal the opposition ruling.72 Estoppel only applies
if the patent is revoked altogether; there is no longer a valid
patent, so there are no longer any legal arguments for or
against it.73 As a part of the overall argument for global patent
harmonization, which began with TRIPS, there has been a
push to institute a post-grant opposition type system in the
United States.74
After the opposition period has passed, some European
countries allow validity to be challenged on any grounds, in
some cases even without a case or controversy—a standing requirement for any U.S. case, including patent cases.75 If the patent is found invalid in one of these proceedings it is only invalid in that jurisdiction, e.g. a German court can only invalidate
a patent in Germany.76
D. ADDING AIA: FUTURE CHANGES TO U.S. PATENT LAW
Serious calls for patent reform began in 2004 when the National Academy of Sciences (NAS) released a report outlining
the shortcomings of the current patent regime and proposing
solutions.77 The report found seven issues in the current regime
including an inability to quickly respond to new technologies,
issuing too many low quality patents, excessive periods of time
required to defend the validity of a patent, and inconsistencies
with international patent regimes.78 The quality of patents was
especially problematic, as low quality patents are more likely to
be litigated and invalidated, creating uncertainty and under-

70. Carlson & Migliorini, supra note 43, at 278.
71. See EPC, supra note 50, at art. 99; Carlson & Migliorini, supra note
43, at 276.
72. EPC, supra note 50, at art. 107.
73. Carlson & Migliorini, supra note 43, at 280.
74. See H.R. 2795, 109th Cong. § 321 (2005).
75. Countries that allow validity challenges include Germany, France, the
U.K., and Switzerland. See Malwina Mejer & Bruno van Pottelsberghe de la
Potterie, Economic Incongruities in the European Patent System 6 (ECARES,
Working Paper No. 2009-003, 2009).
76. See id. at 6; Carlson & Migliorini, supra note 43, at 276.
77. NAT’L RESEARCH COUNCIL, supra note 4; H.R. REP. NO. 112-98, at 39
n.5 (2011).
78. See NAT’L RESEARCH COUNCIL, supra note 4, at 41–80.
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mining the goal of the patent system.79 When fully litigated,
more than forty-six percent of U.S. patents are found invalid.80
This statistic, however, may be expected. Patent litigation is
extremely expensive, so truly questionable patents are far more
likely to make it through trial without being settled.81 Possible
causes for the decrease in patent quality include an overburdened USPTO examiner staff, a high patent approval rate, uncertainty regarding the standards for newly patentable technologies, and a dilution of the non-obviousness requirement.82
The NAS recommended, among other things, a reinvigoration
of the non-obviousness requirement, a post-grant review system similar to the one used by the EPO, and an increase in the
resources available to the USPTO.83 In addition to these
strength issues, as the number of patent applications has increased, the examiner staff has remained essentially the same
size, leading to a backlog of more than 700,000 patent applications in 2010 and a wait of nearly fifteen months before the
first office action.84
As part of his Strategy for American Innovation, on September 16th, 2011, President Obama signed into law the AIA.85
As the first major overhaul to the U.S. patent regime in nearly
sixty years, this broad-sweeping patent reform bill claims to increase the efficiency of the patent office, ease of filing, and
strength of issued patents, while bringing the American system
in line with the patent regimes of most other developed na-

79. Id. at 46–47.
80. Carlson & Migliorini, supra note 43, at 264.
81. See NAT’L RESEARCH COUNCIL, supra note 4, at 48–49.
82. Id. at 51–62. From 1993 to 1998, eighty-five percent to ninety-seven
percent of all patents were eventually allowed. Id. at 53.
83. Id. at 87–108.
84. Id. at 65; Unreasonable Patent Application Delay and the USPTO
(July
9,
2010,
3:11
PM),
Backlog,
PATENTLY-O
http://www.patentlyo.com/patent/2010/07/unreasonable-patent-applicantdelay-and-the-uspto-backlog.html.
85. See A Strategy for American Innovation: Driving Towards Sustainable
(Sept.
2009),
Growth
and
Quality
Jobs,
WHITEHOUSE.GOV
http://www.whitehouse.gov/administration/eop/nec/StrategyforAmericanInnov
ation/; Josh Lowensohn, Patent Overhaul Signed Into Law by Obama, CNET
NEWS (Sept. 16, 2011, 1:22 PM), http://news.cnet.com/8301-13578_3-2010751938/patent-overhaul-signed-into-law-by-obama/.
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tions.86 The momentum towards patent harmonization was begun by TRIPS, but at the time TRIPS was signed, only minor
changes were made to the U.S. system.87 The AIA, on the other
hand, has made many major changes to the current U.S. patent
system, a number of which serve to harmonize the American
patent system with other industrial nations.88 For example, the
first and most discussed change is the shift from a “first-toinvent” to a “first-to-file” system.89 The goals of this change include reducing confusion in the priority system, reducing the
initial hurdles in obtaining a valid patent, and streamlining the
patent system.90 In 2010, 211 patent applications were in interference, accounting for roughly .02% of all pending patent applications.91 By creating an objective, easy-to-determine date to
determine priority, interference proceedings to determine priority will no longer be necessary.92 This will streamline and speed
up the process of obtaining a patent by removing another time
and resource intensive step in the prosecution process.93 Despite this change, a patent will still only issue to a person who
actually invented—rather than copied or reverse engineered—
the invention in question. If an inventor wishes to challenge
whether a previous filer is a true inventor she may do so under
a newly established derivation proceeding before the Patent

86. Leahy-Smith America Invents Act, Pub. L. No. 112-29, 125 Stat. 284
(2011) (to be codified in scattered sections of 35 U.S.C.); Press Release, Merchant & Gould P.C., The America Invents Act Becomes Law (Sept. 16, 2011),
available
at
http://www.merchantgould.com/CM/NewsAlerts/
The%20America%20Invents%20Act%20One%20Becomes%20Law.pdf.
87. See MERGES & DUFFY, supra note 45, at 58.
88. For a comprehensive mark-up of the current U.S. patent law, noting
all American Invents changes, see DENNIS CROUCH, A MARK-UP AND
COMMENTARY ON THE LEAHY-SMITH AMERICA INVENTS ACT (2011) (on file with
the author).
89. See Press Release, Merchant & Gould P.C., supra note 86, at 1.
90. H.R. REP. NO. 112-98, at 40–42 (2011).
91. ACCOUNTABILITY REPORT 2010, supra note 44, at 128.
92. Janelle Waack, IP: Interference Proceedings in Post-AIA America,
INSIDE COUNSEL (Feb. 14, 2012), http://www.insidecounsel.com/2012/02/14/ipinterference-proceedings-in-post-aia-america.
93. “Interference proceedings can take years to complete (even if there is
no appeal to the United States Court of Appeals for the Federal Circuit), cost
hundreds of thousands of dollars, and require extensive discovery.” H.R. REP.
NO. 112-98, at 41 (2011). Some new technologies can be tied up in interference
for the bulk of their relevant patent periods; for example, integrated circuits,
polymer chemistry, and lasers were all tied up in interference during the bulk
of their relevant patent protection periods. Lemley, supra note 29, at 611–13.
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Trial and Appeal Board (PTAB), formerly the BPAI.94 To accommodate the new system, the priority and prior art rules
have been changed.95 All priority dates are based on the filing
date of the application or any application that it claims priority
to.96 Prior art now includes any publication prior to the effective filing date, except any publications or disclosures made by
the inventor within one year of the filing date.97 The goal of this
provision is to achieve all the benefits of a first-to-file system
while still allowing for flexibility for inventors who need time to
submit a patent application.98
The second change is an increase in the ability of third parties to submit documents for review during the patent application process.99 Currently, third parties can only submit patents
or publications without explanation within two months after a
patent is published.100 Under the new law, third parties will be
able to submit “any patent, published patent application, or
other printed publication of potential relevance to the examination of the application,” as well as explanations as to their relevance.101 The fear is, under the current regime, the limitations
as to what can be submitted, as well as the restrictions on explanations, may decrease the value of these submissions and
could even deter their use.102 These changes should increase
the strength of issued patents by ensuring all relevant information is disclosed and given due consideration.103
The third change is the removal of the “best mode” as a
challenge to the validity or enforcement of a patent.104 Under
the current regime, in order to obtain a patent the applicant
must disclose what they see to be the best way to build or perform the claimed invention at the time the application is filed—

94. Leahy-Smith America Invents Act, Pub. L. No. 112-29, sec.7, § 6, 125
Stat. 284, 313 (2011); H.R. REP. NO. 112-98, at 42.
95. H.R. REP. NO. 112-98, at 40–43.
96. Leahy-Smith America Invents Act, sec. 3(a).
97. Id. at sec. 3, pt. b.
98. H.R. REP. NO. 112-98, at 42.
99. Id. at 45.
100. 37 C.F.R. § 1.99 (2011); MPEP, supra note 2, at § 1134.01.
101. Leahy-Smith America Invents Act, sec. 8.
102. H.R. REP. NO. 112-98, at 48–49.
103. Id. at 40.
104. Leahy-Smith America Invents Act, sec. 15(a).

FOSSEN_PROOF (DO NOT DELETE)

2013]

THE POST-GRANT PROBLEM

2/11/2013 11:51 AM

585

a subjective standard.105 If the patent does not disclose the best
mode it may be unenforceable or invalid.106 There is no best
mode requirement in Europe.107 After AIA, an applicant will
still be required to disclose the best mode in the application in
order to obtain the patent, but a potential infringer will no
longer be able to invalidate the patent based on a lack of best
mode disclosure.108 By changing this requirement, the United
States will harmonize its infringement defenses.109 Additionally, by removing a possible challenge, AIA may reduce the
amount of validity litigation, and thereby strengthen issued patents.110
The final major change is the introduction of a post-grant
review and an inter partes review before the PTAB.111 A postgrant review may be filed by any party who is not an owner of
the patent within nine months of issuance or reissuance of a
patent.112 If the patent at issue is a reissued patent, only claims
new to a reissue can be challenged.113 Issues beyond patentability generally cannot be brought up in the post-grant review, but
evidence beyond written prior art can be presented.114 A postgrant review may be allowed upon “a showing that the petition
raises a novel or unsettled legal question that is important to
other patents or patent applications.”115 A post-grant review
cannot be filed after a civil suit challenging validity is filed, and
will automatically stay any such suits filed after the review.116
The final decision can only be appealed to the Court of Appeals
for the Federal Circuit, and the parties are estopped from arguing the issues again in civil court.117 The parties are permitted,
however, to settle prior to the decision and thereby avoid estop-

105. MPEP, supra note 2, at § 2165.
106. CROUCH, supra note 88, at 120.
107. NAT’L RESEARCH COUNCIL, supra note 4, at 121.
108. CROUCH, supra note 88, at 55.
109. NAT’L RESEARCH COUNCIL, supra note 4, at 121.
110. Id.
111. Press Release, Merchant & Gould P.C., supra note 86.
112. Leahy-Smith America Invents Act, Pub. L. No. 112-29, sec. 6(d), 125
Stat. 284, 306 (2011).
113. Id.
114. Id.
115. Id. at sec. 6(a), § 324(b). It is currently uncertain what this will entail,
but it is possible that it will open up the post-grant review to a much larger
range of issues than the prior reexamination system allowed.
116. Id. at sec. 6(e), § 325.
117. Id.
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pel.118
The inter partes review can be brought up by any party
who is not an owner of the patent after the later of the nine
month period for post-grant review or after the termination of a
post-grant review.119 Like the prior inter partes reexamination,
only patentability can be challenged and only printed prior art
can be submitted.120 The standard for instituting an inter
partes review is “reasonable likelihood” to prevail, while the
standard under inter partes reexamination was “substantial
new question of patentability.”121 Unlike an inter partes reexamination, which can be filed during or after civil litigation, an
inter partes review cannot be filed after a civil suit challenging
validity is filed and will automatically stay any such suits filed
after the review.122 The final decision can only be appealed to
the Court of Appeals for the Federal Circuit, and the parties
are estopped from arguing the issues again in civil court.123 The
parties are permitted, however, to settle prior to the decision
and thereby avoid estoppel.124 Settlement was not allowed under the inter partes reexamination and decisions were appealed
first to the BPAI, and only after BPAI ruling to the Federal
Circuit.125 These new changes generally take effect on September 16, 2012.126
While post-grant review and inter partes review share
many features, including the ability to settle, appeals directly
to the Federal Circuit, and automatic stays of any subsequent
validity litigation in the federal courts, it is critical to highlight
the important differences.127 The most important difference is
what can be presented as evidence of patentability. In post-

118. Id.
119. Id. at sec. 6(a).
120. Id; see 35 U.S.C. § 301 (2006); MPEP, supra note 2, at § 2205.
121. Leahy-Smith America Invents Act, sec. 6(a); MUELLER, supra note 3,
at 257, 259.
122. Leahy-Smith America Invents Act, sec. 6(a); 35 U.S.C. § 318; see
MPEP, supra note 2, at § 2205.
123. Leahy-Smith America Invents Act, sec. 6(a).
124. Id.
125. MPEP, supra note 2, at §§ 2659, 2674–83; MUELLER, supra note 3, at
263–65.
126. CROUCH, supra note 88, at 8.
127. Leahy-Smith America Invents Act, secs. 6(a), (d).
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grant review the petitioner can present printed prior art (including publications and published patents) as well as declarations and affidavits showing expert opinions, statements of the
inventor, or any other information relevant to the original patentability.128 Inter partes review, however, remains limited to
printed prior art.129 Also, changes have been made to what can
be challenged in the proceedings. In post-grant review, challenges are no longer limited to patentability, though that is still
the major use.130 A post-grant review can be allowed for “showing that the petition raises a novel or unsettled legal question
that is important to other patents or patent applications” as
well as any deficiencies in the declaration.131 Inter partes review still only allows challenges based on patentability.132 The
final major difference is timing. Post-grant review must be conducted within the first nine months of issuance or reissuance of
a patent.133 Inter partes review, on the other hand, may only be
filed after the nine month period for post-grant review has expired or after the termination of a post-grant review, whichever
is later, provided it is prior to the end of the patent period.134
These differences combine to make the post-grant review more
restrictive than inter partes review with regards to time, but
more flexible with regards to what validity issues can be challenged and what evidence can be presented.
All of these major changes bring the U.S. patent regime
more into line with the patent systems of other industrialized
nations. The shift to a first-to-file system and the removal of
the best mode defense in infringement cases, in particular, remove aspects that were once characteristic of only the U.S. patent regime.135 The changes also go far beyond the standardized
requirements of TRIPS in harmonizing the patent law of the
major patent countries.

128. Id. at sec. 6(d).
129. Id. at sec. 6(a).
130. Id. at sec. 6(d).
131. Id. There is a concern that this standard is ill defined, but it will no
doubt open up other avenues of challenge within post-grant reviews as compared to reexamination.
132. Id. at sec. 6(a).
133. Id. at sec. 6(d).
134. Id. at sec. 6(a).
135. MERGES & DUFFY, supra note 45, at 64–65; See NAT’L RESEARCH
COUNCIL, supra note 4, at 124.

FOSSEN_PROOF (DO NOT DELETE)

588

2/11/2013 11:51 AM

MINN. J. L. SCI. & TECH.

[Vol. 14:1

III. ANALYSIS
Much has been said about the shift from a first-to-invent to
a first-to-file system in the United States, so it will not be addressed in this Note.136 This Note will instead address the
changes to how a patent’s validity can be challenged after issuance and discuss whether the new system will meet the goals
set out by Congress when it enacted AIA.
A. THE POST-GRANT PROBLEM: THE CHANGES AND FAILINGS OF
AIA
1. Best Mode
The most prominent reason for changing the “best mode”
defense against infringement is international harmonization of
patent law enforcement.137 The United States requires that the
best mode of practicing the invention be included in the patent
application.138 Many have argued that this requirement is not
necessary and is counterproductive.139 Any use of this defense
is necessarily subjective, because it is difficult to know what
the state of knowledge was at the time of the application.140
The European system has no such best mode requirement, and
therefore no analogous infringement defense.141 By removing
the defense AIA harmonizes patent law enforcement with the
international norm.142
Removing the best mode defense may also further other
goals of patent reform including increasing the strength of issued patents and decreasing litigation.143 Due to Federal Rule
of Civil Procedure 13(a), claims of invalidity are compulsory
counterclaims to any infringement suit.144 If a party does not
136. See, e.g., Charles R. B. Macedo, Note, First-to-File: Is American Adoption of the International Standard in Patent Law Worth the Price?, 1988
COLUM. BUS. L. REV. 543, 543–46 (giving an overview of many arguments regarding first-to-file priority).
137. See H.R. REP. NO. 112-98, at 52 (2011).
138. 35 U.S.C. § 112 (2006).
139. H.R. REP. NO. 112-98, at 52 (2011).
140. See id.
141. See EPC, supra note 50, at art. 78.
142. See NAT’L RESEARCH COUNCIL, supra note 4, at 121.
143. See Press Release, Merchant & Gould P.C., supra note 86.
144. FED. R. CIV. P. 13(a); Polymer Indus. Prods. v. Bridgestone/Firestone,
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claim that a patent is invalid when they are sued for infringement, then she cannot bring an invalidity suit after the infringement claim is litigated. Because of this, nearly every time
a person is sued for infringement, they are likely to bring an
invalidity counterclaim. Therefore, while removing the best
mode defense, may reduce the ways in which an invalidity suit
may be successful, it will probably not reduce validity litigation
on its own. It may, however, by removing an extremely subjective defense to infringement, strengthen patents overall.145
2. Post-Grant Review
Like the removal of the “best mode” defense, the institution
of the post-grant review is an attempt at international patent
harmonization.146 For the most part, the post-grant review mirrors the opposition proceedings in Europe. Both proceedings
must be initiated within the first nine months after a patent is
issued, both are contentious proceedings between two parties,
and, in both, evidence can be admitted beyond printed prior
art.147 The issues that may be raised are also more similar now.
Inc., 347 F.3d 935, 938 (Fed. Cir. 2003) (holding that patent infringement
claims are compulsory counterclaims in declaratory judgment actions asserting non-infringement and invalidity); Akzona, Inc. v. E. I. Du Pont de
Nemours & Co., 662 F. Supp. 603, 618 (D. Del. 1987) (“In the instant case,
both the declaratory judgment action and the counterclaim arise out of the
same patents and both seek to define the scope and determine the validity of
those patents. Such a situation is clearly within the mandate of Rule 13(a).”);
Deering Milliken, Inc. v. Koratron Co., 293 F. Supp. 518, 522 (S.D.N.Y. 1968)
(“[I]f this Court were to view the California complaint as a claim for infringement, it would in its discretion stay the action for declaratory relief because
Deering Milliken must raise the issue of invalidity as a compulsory counterclaim in California, and therefore, the subject matter of both suits would be
identical.”).
145. See H.R. REP. NO. 112-98, at 52 (2011) (explaining the rationale behind removing the best mode defense).
146. See generally id. at 39–40 (highlighting the importance of harmonization in the patent reform debate). Additionally,
[h]armonization’s major benefit is that it cuts legal fees, particularly
for pharmaceutical inventions, whose applications are typically filed
in several countries. Second, harmonization cuts down on “forum
shopping” in multicountry litigation enforcement efforts. Third, harmonization creates certainty of patent rights. Businesses need to
know what actions in different countries are going to be covered by a
given patent. Fourth, harmonization creates value. The more certainty you bring to the scope of a patent worldwide, the more value you
create.
Michael D. Kaminski, Patents and Property: International Harmonization, 4
MODERN DRUG DISCOVERY 36, 37 (2001).
147. Compare Leahy-Smith America Invents Act, Pub. L. No. 112-29, sec.
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As previously stated, in an opposition one may raise issues including a lack of novelty, lack of inventive step, lack of industrial application, lack of adequate disclosure, an inadmissible
amendment, or that the subject matter is not an invention or a
patentable subject matter.148 In the post-grant review issues of
patentability—including novelty and non-obviousness—may be
raised in addition to any deficiencies in disclosure.149 Disclosures may be deficient when they do not clearly state the invention in such a way as to enable a “person skilled in the pertinent art or science to make and use the invention without
involving extensive experimentation.”150 Previously, only issues
of patentability could be raised.151 On February 9, 2012, the
USPTO submitted for public comment the proposed procedural
rule for post-grant review.152 Under the current rules the postgrant review will be a trial with limited set motions, amendments, and discovery, and a party would be allowed to amend
the claim at issue to address the questions brought forth by the
post-grant review.153 While the USPTO defines a trial as a contested case,154 it is unclear if there will be oral argument like
the European system or merely paper motions and petitions,
much like current proceedings.155 There is one major difference
between the two systems. The opposition system only invokes
estoppel when a patent is entirely revoked, while the post-grant
review system estops all parties from arguing any issue that
was raised or reasonably could have been raised in the proceedings regardless of the outcome.156 In general, however, the new
post-grant review is quite similar to the opposition system established in Europe.

6(d), 125 Stat. 284, 306 (2011), with EPC, supra note 50, at art. 99.
148. MUIR ET AL., supra note 51, at 237; EPC, supra note 50, at art. 100.
149. Leahy-Smith America Invents Act, sec. 6(d).
150. MPEP, supra note 2, at § 608.01(g).
151. MUELLER, supra note 3, at 257, 259–61.
152. 77 Fed. Reg. 6868 (Feb. 9, 2012).
153. 77 Fed. Reg. 7060 at 7079–80 (Feb. 10, 2012).
154. Press Release, Sughrue Mion PLLC, USPTO’s Rule Proposals for PostGrant Review (Feb. 13, 2012) available at http://www.sughrue.com/USPTOSRule-Proposals-for-Post-Grant-Review-02-13-2012/.
155. See Leahy-Smith America Invents Act, Pub. L. No. 112-29, sec.
6(a),(d), 125 Stat. 284, 299, 306 (2011).
156. Id. at sec. 6(a); Carlson & Migliorini, supra note 43, at 280.
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Despite the importance of harmonization, a decrease in litigation is a more prominent goal of the post-grant review.157 If
there is an increase in the use of post-grant review over the inter partes reexamination, the combination of the number of issues able to be raised with the robust estoppel provisions will
reduce the number of invalidity suits that can be brought in
federal court.158 Many issues existed in the old system, which
reduced its overall use.159 The new system addresses many of
these.160 First, there is now an option for settlement.161 Second,
the petitioners have greater involvement in the proceedings,162
and finally, much more can be produced as evidence and more
issues can be brought up.163 As previously established, the postgrant system is very similar to the opposition system, and evidence shows that around five percent of patents in Europe trigger an opposition proceeding.164 If the post-grant review was
used at a similar rate, this alone would be a significant increase over the approximately 0.3% of patents subject to inter
partes and ex partes reexaminations in the United States.165
And when considered in light of the fact that, unlike validity
challenges in federal courts, which have a clear and convincing
evidence standard, post-grant review would have a preponderance of the evidence standard, many seeking to invalidate a patent may find the new post-grant system an attractive option,
increasing overall use. Furthermore, under the current regulations all post-grant reviews must be completed within one
year.166
There are significant institutional differences between the
157. See generally H.R. REP. NO. 112-98, 38–40 (2011) (outlining the purpose of America Invents).
158. Id.
159. Id.
160. See Carlson & Migliorini, supra note 43, at 266–70.
161. Leahy-Smith America Invents Act, sec. 6(a).
162. Compare id. with MPEP, supra note 2, at §§ 2654–2659 (highlighting
that a settlement option did not exist previously and has been added in America Invents).
163. Compare Leahy-Smith America Invents Act, sec. 6(a) with MPEP, supra note 2, at § 2658 (highlighting the different evidence rules between the old
system and the system under America Invents).
164. DIETMAR HARHOFF, INST. FOR INNOVATION RESEARCH, ECONOMIC
COST-BENEFIT ANALYSIS OF A UNIFIED AND INTEGRATED EUROPEAN PATENT
LITIGATION SYSTEM 45 (2009).
165. ACCOUNTABILITY REPORT 2010, supra note 44, at 129, 137; Carlson &
Migliorini, supra note 43, at 269.
166. 77 Fed. Reg. 48756, 48757 (Aug. 14, 2012).
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United States and Europe, however, which will dampen the
overall increase in use. First, patent infringement and court
based validity challenges are handled on a country by country
basis in Europe.167 If one wishes to avoid wide scale litigation
across all EPC countries she must invalidate the patent at the
EPO level through opposition.168 U.S. patents, on the other
hand, are litigated between parties only once in the federal
courts, not in each individual district.169 A single decision regarding invalidity from either the PTAB or the federal courts
will be binding across the entire country.170 Because both venues have the same result, it is unlikely that a potential petitioner will choose post-grant review over an invalidity suit for
that reason alone.
Second, opposition has much less robust estoppel provisions.171 In Europe only the patent holder is estopped from arguments, and only if the patent is revoked in its entirety.172
This makes the proceeding much more friendly to the petitioner, as there are far fewer risks if the opposition fails and an infringement proceeding is brought.173 All defenses to that infringement are still available to the potential petitioner.174 The
post-grant review has a much higher risk.175 Not only is the patent holder estopped if the patent is revoked, both she and the
petitioner are also estopped from raising any issue that was or
could have been raised in the proceedings.176 If a post-grant re-

167. See Carlson & Migliorini, supra note 43, at 276.
168. Id.
169. The concept of res judicata and collateral estoppel apply to patent cases in the federal court system. See Parklane Hosiery Co., Inc. v. Shore, 439
U.S. 322, 327–28; David P. Hoult v. Jennifer Hoult, 157 F.3d 29, 31–32 (1st
Cir. 1998); Car Carriers, Inc. v. Ford Motor Co., 789 F.2d 589, 595 (7th Cir.
1989).
170. See Parklane Hosiery Co., Inc., 439 U.S. at 327–28; Hoult, 157 F.3d at
31–32; Car Carriers, Inc., 789 F.2d at 595.
171. See Carlson & Migliorini, supra note 43, at 280.
172. Id.
173. See id.
174. See id.
175. Compare id., with Leahy-Smith America Invents Act, Pub. L. No. 11229, sec. 6(a), 125 Stat. 284, 299 (2011) (explaining possible reasons for low utilization of reexamination proceedings and highlighting the changes that increase these risks).
176. Leahy-Smith America Invents Act, sec. 6(a).
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view fails and an infringement proceeding is brought against
the petitioner, a major defense against infringement has been
removed.177 While the evidence standard is lower in post-grant
review, some would still be unwilling to take this risk in case of
litigation.178 The robust estoppel provisions will streamline the
litigation process for patents that have gone through post-grant
review, but may reduce the overall use of the post-grant review
system and, as a result, may reduce the overall effect of AIA on
reducing patent litigation.
Finally, there is an institutional bias in the United States
for counterclaims.179 In fact, invalidity is a compulsory counterclaim when there is an infringement suit.180 In Germany, on
the other hand, validity is not even permitted as a defense in
an infringement proceeding, as invalidity must be claimed and
litigated in a separate proceeding.181 AIA does allow for a stay
in infringement litigation if a potential infringer wishes to institute a post-grant review instead of a counterclaim.182 This
option, however, is unlikely to be used with any real frequency.
First, invalidity is a natural defense in any infringement litigation, and there are very few practicing patent litigators who are
also eligible and experienced in practicing in proceedings before
the PTAB.183 With the exception of the new pro hac vice recently allowed by the USPTO for the new administrative issues only (inter partes review, post-grant review, covered business
method review, and derivation), in order to bring or defend
177. See id.
178. Additionally, the lower evidentiary standard is already in place in inter partes reexamination. If the lower standard were to increase the number of
individuals willing to use the proceedings, the increase would already be factored into the data regarding old proceedings.
179. See FED. R. CIV. P. 13(a); Polymer Indus. Prods. v. Bridgestone/Firestone, Inc., 347 F.3d 935, 938 (Fed. Cir. 2003); Akzona, Inc. v. E. I.
Du Pont de Nemours & Co., 662 F. Supp. 603, 618 (D. Del. 1987); Deering Milliken, Inc. v. Koratron Co., 293 F. Supp. 518, 522 (S.D.N.Y. 1968).
180. Polymer Indus. Prods., 347 F.3d at 938.
181. JAN WILLEMS, SOME REMARKS ABOUT INVALIDITY AS A DEFENSE IN
EUROPEAN PATENT INFRINGEMENT PROCEEDINGS (2001), available at
http://www.softic.or.jp/symposium/open_materials/10th/en/willems2-en.pdf.
182. Leahy-Smith America Invents Act, sec. 6(a).
183. In order to be eligible to practice before the PTAB one must pass the
Patent Bar Exam. To even be eligible to sit for the exam one must generally
have at least an undergraduate degree in a science or technology related field.
U.S. PATENT & TRADEMARK OFFICE, GENERAL REQUIREMENTS BULLETIN FOR
ADMISSION FOR REGISTRATION TO PRACTICE IN PATENT CASES BEFORE THE
UNITED STATES PATENT AND TRADEMARK OFFICE 1–7 (2012), available at
http://www.uspto.gov/ip/boards/oed/grb.pdf.
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against a post-grant review the lawyer must be registered to
practice before the USPTO, which requires a science background and an admissions exam.184 While most large firms will
have both prosecutors and litigators, it may not be the case
that they have a litigator who has also been admitted to practice before the USPTO. While they can utilize pro hac vice, they
will still require the assistance of a registered patent attorney
to assist in the proceedings.
Additionally, it is very possible that patent holders, as part
of their litigation strategy, will wait until after the nine-month
period has expired to begin sending cease-and-desist letters
and filing infringement suits. There is no statute of limitations
for patent infringement, but monetary damages are limited to
infringements occurring in the six years prior to the filing of
the suit.185 Even when adding on the three-year average prosecution period, waiting nine months after issuance will not limit
the legal remedies of the patent holder.186 Yet by following this
strategy the patent holder avoids giving notice of possible infringement issues and thereby avoids having her patent’s validity challenged in a venue that only requires a preponderance of
the evidence.187 It is important to note, however, that this
strategy may reduce the damages that can be collected by the
patent holder, especially when the patent is for a product.188 If
the subject of a patent is not labeled with the proper patent information, the infringer is only liable for any infringement that
occurs after it has knowledge of the patent.189 When the patent
in question is for a machine, manufacture, or composition of
matter, or if the patent is properly labeled to indicate that
there is a patent, no actual knowledge on the part of the in-

184. Id.; James Donald Smith, Message from Chief Judge James Donald
Smith, Board of Patent Appeals and Interferences: USPTO Discusses Key Aspects of New Administrative Patent Trials, USPTO.GOV, http://www.uspto.gov/
aia_implementation/smith-blog-extravaganza.jsp#heading-4 (last updated
May 21, 2012).
185. 35 U.S.C. § 286 (2006).
186. Patents protect inventions starting on the date that the application is
filed. 35 U.S.C. § 154(a).
187. See 35 U.S.C. § 286; Leahy-Smith America Invents Act, sec. 6(a).
188. 35 U.S.C. § 287. Processes are exempt from the labeling requirement.
35 U.S.C. § 287(a).
189. Id.
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fringer is required.190 This provision applies to monetary damages only; injunctions can still be sought as filing of a suit constitutes notice on the part of the patent holder.191 The similarities between the new post-grant review and the opposition
system, therefore, may lead to an increase in the use of postgrant review, but the differences in the system as well as the
institutional differences between patent litigation in Europe
and the United States will significantly dampen this increase.
In addition to all of these factors, the fees for filing a post-grant
review are large. To file a post-grant review of up to twenty
claims is $35,800, and each additional claim is $800.192
That being said, if a patent goes through the post-grant review proceeding and survives, it will be significantly stronger,
at least with regards to the petitioner. The petitioner will be
unable to argue that the patent is invalid on any of the possible
post-grant review grounds and will have to overcome the clear
and convincing evidence standard for any other validity issues.193 This will make it much harder to invalidate a patent
that has gone through post-grant review.
3. Inter Partes Review
Like post-grant review, inter partes review can increase the
strength of patents and as a result reduce validity litigation.194
The combination of estoppel provisions and the increased burden of proof in federal courts would make it more difficult to
successfully challenge the validity of a patent that has gone
through an inter partes review. As it is currently structured,
however, there are only two major changes to the inter partes
review from the old inter partes reexamination: the addition of
a settlement option and the shift to a reasonable likelihood
standard for initiating a proceeding.195 These additions alone
are unlikely to increase the use of inter partes review over inter
partes reexamination.196 The same barriers to use that exist in

190. Id.
191. Id.
192. AIA Frequently Asked Questions, USPTO.GOV, http://www.uspto.gov/
aia_implementation/faq.jsp#heading-8 (last visited Oct. 4, 2012).
193. See 35 U.S.C. § 282; Leahy-Smith America Invents Act, Pub. L. No.
112-29, sec. 6(a), 125 Stat. 284, 299 (2011).
194. See Leahy-Smith America Invents Act, sec. 6(a).
195. Id.
196. See generally id. (outlining all changes in patent law to institute the
inter partes review).
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post-grant review exist in this context as well, with one notable
exception. The inter partes review can be filed after the ninemonth publication period.197 There is still, however, an institutional bias towards validity litigation in response to an infringement suit, and there are very few practitioners who are
willing and able to practice before the PTAB in inter partes reviews.198 Additionally, the old limits to what issues can be
raised—a significant new issue of patentability only—and what
evidence can be presented—printed prior art only—still exist.199 These limits are arguably more of a barrier to the use of
the inter partes reexamination and the new inter partes review
than the inability to settle.200 As a result, it is unlikely that inter partes review will be used any more frequently than inter
partes reexamination has been in the past, and the minor
changes that AIA has made to this proceeding are unlikely to
increase the strength of issued patents or decrease validity litigation.
B. A SIMPLE SOLUTION: MORE FRONT-END REVIEW
International patent regime harmonization is accomplished by the “best mode” changes and the post-grant review,
and U.S. patents can be strengthened by the new proceedings if
they are used. U.S. patent strength, however, will not be significantly increased, nor will validity litigation be decreased, because it is unlikely that there will be a significant increase in
the use of the post-grant review or inter partes review over the
inter partes reexamination. In fact, due to civil procedure rules,
validity litigation in response to infringement actions may never be reduced, but patent strength may still be increased
through a more stringent pre-grant review. The increase in pa-

197. Id.
198. See FED. R. CIV. P. 13(a); Polymer Indus. Prods. v. Bridgestone/Firestone, Inc., 347 F.3d 935, 938 (Fed. Cir. 2003); Akzona, Inc. v. E. I.
Du Pont de Nemours & Co., 662 F. Supp. 603, 618 (D. Del. 1987); Deering Milliken, Inc. v. Koratron Co., 293 F. Supp. 518, 522 (S.D.N.Y. 1968). These cases
establish the compulsory counterclaim requirement in the United States.
199. Compare 35 U.S.C. § 312(a) (2006), and MPEP, supra note 2, at §
2609, with Leahy-Smith America Invents Act, sec. 6(a) (outlining the old requirements and highlighting the lack of alternation in America Invents).
200. See generally Carlson & Migliorini, supra note 43 (explaining the reasons for the low utilization of the inter partes reexamination).
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tent strength, in turn, may shift the balance between patent
holders and alleged infringers in favor of the holders, increasing the overall rate of settlement in these cases. As previously
stated, possible causes for the decrease in patent quality include an overburdened USPTO examiner staff, a high patent
approval rate, uncertainty as to the standards for newly patentable technologies, and a dilution of the non-obviousness requirement.201 By addressing these concerns and narrowing
claim construction, the strength of issued patents will be increased. The following are a few of the many possible reform
measures that could be taken to ensure more front-end review
and increase the quality of issued patents.202 These are merely
suggestions and it is not the scope of this Note to address the
merits of these in any depth.
1. Third-Party Submissions
The AIA already attempts to assist in strengthening frontend review by increasing the ability of third parties to submit
relevant prior art prior to submission.203 Under the current system, a third party could submit published prior art, but could
not even highlight the relevant portions to assist the examiners, let alone explain why the submission was relevant.204 By
allowing third parties to submit more information in an effective manner, it is more likely that examiners will have access to
all relevant prior art before making decisions about the novelty
and obviousness of an invention.205 This means that it is less
likely that previously unknown prior art will come up in postgrant proceedings or federal court invalidity suits, thereby the
strength of issued patents will be increased. The new provision
will only be helpful to the extent that patent examiners are
able to review the incoming information.
2. Narrower Claim Construction, Stronger Non-Obviousness
Requirement
Currently, applicants can claim the broadest possible invention at the initial stages.206 This means that it is possible
201. See NAT’L RESEARCH COUNCIL, supra note 4, at 80.
202. Other reforms may include construing ambiguous claims against the
drafter, limiting continuations, etc.
203. Leahy-Smith America Invents Act, sec. 8(a).
204. 37 C.F.R. § 1.99 (2011); MPEP, supra note 2, § 1134.
205. H.R. REP. NO. 112-98, 49 (2011).
206. Phillips v. AWH Corp., 415 F.3d 1303, 1316–17 (Fed. Cir. 2005) (en
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that an individual may receive a patent that covers more than
just what they invented.207 This is often considered a reward
for being the first to come up with a great idea, but overly
broad patents can lead to increased infringement and validity
litigation.208 Courts, therefore, are often required to narrow
claims in order to make the patent true to the original invention.209 The AIA did not address the scope of claims, so, in order
to fix these issues, narrower claims should be required at the
onset by the USPTO.210 As the breadth of claims is typically determined by the USPTO examiners, USPTO regulations would
need to be amended to ensure narrower claim scope.211 Narrower claims could be established by increasing the number of
rejections for over-breadth or non-enablement, defining more
precisely the scope of the claims through the communications of
the applicant with the examiner and the USPTO, and by requiring more statements by the examiners at issuance.212 Right
now, examiners are allowed to submit a “Reason for Allowance”
with the patent to explain why it was allowed if the record as a
whole does not reflect the reasons why it was allowed.213 These
statements can be used as evidence for claim breadth in litigation, but are generally not required to be written when the application is allowed.214 Additionally, the claimed subject matter
could also be narrowed through a more stringent non-

banc) (“The Patent and Trademark Office (‘PTO’) determines the scope of
claims in patent applications not solely on the basis of the claim language, but
upon giving claims their broadest reasonable construction . . . .”); MPEP, supra
note 2, at § 2111.
207. See Phillips, 415 F.3d at 1316–17.
208. Overly broad patents also cause an anti-commons problem in new
technologies, which stifles innovation. See Mark A. Lemley, Patenting Nanotechnology, 58 STAN. L. REV. 601, 618–19 (2005).
209. See NAT’L RESEARCH COUNCIL, supra note 4, at 25.
210. NAS recommends narrowing claims on overly broad patents after issuance. NAT’L RESEARCH COUNCIL, supra note 4, at 96. I, however, am arguing for narrowing the claims pre-issuance and thereby increasing the predictability of patent enforcement.
211. See MPEP, supra note 3, § 2173.04. The breadth of a claim can also be
determined by the federal courts after issuance, but the large deference given
to the USPTO limits the courts’ effectiveness.
212. 37 C.F.R. § 1.104(e) (2011); MPEP, supra note 2, § 1302.14.
213. 37 C.F.R. § 1.104(e); MPEP, supra note 2, § 1302.14.
214. 37 C.F.R. § 1.104(e); MPEP, supra note 2, § 1302.14.
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obviousness requirement, as suggested by NAS.215 By making it
harder to clear the obviousness hurdle, fewer claims would be
allowed, and those that do make it would probably be more
narrowly tailored. That being said, NAS only recognized an issue with non-obviousness for business method and genetics patents.216
By narrowing what a patent covers there will be fewer possible prior-art challenges, fewer validity challenges, more consistent interpretation in the courts, and fewer cases of possible
infringement.217 This will, in turn, reduce litigation and
strengthen the patents that are issued. Additionally, as most of
these changes regarding scope will be implemented through
USPTO regulations, no additional legislation will have to be
passed through Congress, allowing for quicker implementation
of necessary reforms. These changes will, however, come at a
cost. There will be less protection for cutting-edge inventions,
more documentation and communication will be required to define the scope of the claims; as a result, there will be a need for
even more USTPO examiners. The non-obviousness requirement will have to be altered by the Federal Circuit.218 Additionally, these changes will signal a major shift in U.S. patent
mentality and will create much confusion and litigation in the
first decade or so.
3. More Examiners
The backlog at the USPTO presents a significant problem
as to the strength of patents.219 There is a serious push to
shorten the amount of time between an application’s submission and a patent’s issuance. Because the staff of examiners at
the USPTO is limited, in order to fulfill the demand each examiner must work on more patents at a quicker rate.220 This may
result in rushing patent applications. Prior-art searches will
not be as thorough, and there will be more reliance on appli-

215. NAT’L RESEARCH COUNCIL, supra note 4, at 59–62.
216. Id. at 87–95. The report also covers ways to reinvigorate the nonobviousness requirement, including expert testimony and a focus on the technological hurdle that the inventor needed to overcome. Id.
217. See Gregory Mandel, The Non-Obvious Problem: How the Indeterminate Nonobviousness Standard Produces Excessive Patent Grants, 42 U.C.
DAVIS L. REV. 57, 91–92 (2008).
218. See id. at 64–65.
219. See NAT’L RESEARCH COUNCIL, supra note 4, at 51, 65.
220. See id. at 65.
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cants to provide all relevant information. By rushing patent
applications, the likelihood that invalidating issues will be
found in issued patents down the road will increase. Prior art
that was not disclosed or found may be discovered in the course
of litigation, or patents may be invalidated for claiming more
than they had a right to. In order to ensure that all applications are thoroughly and carefully reviewed in an acceptable
period of time, there must be an increase in the number of examiners. Additionally, in order to properly institute third-party
submissions and a narrower claim construction, there must be
a sufficiently large staff in order to decrease the likelihood of an
increased backlog. Hiring additional examiners will be an expensive process, though. AIA has attempted to address this issue by granting the USPTO fee-setting authority, but it did not
grant spending authority.221 Under AIA, in order for the funding to be sufficient for the hiring of new examiners the USPTO
will continue to need the budget approval of Congress, and this
will continue until Congress grants the USPTO spending authority as well, establishing it as a financially independent
government organization.222 It is highly unlikely that this will
happen in the near future, as any changes that could result in a
decrease in incoming federal funds will be strongly opposed in
the current budget environment.
IV. CONCLUSION
Beginning in 2004, calls have been made to update the
U.S. patent system, to make it more efficient, to create stronger
patents, to reduce litigation, and to harmonize the U.S. regime
with the international patent community.223 The AIA attempts
to address many of these issues. The question remains, however, if these changes will meet their intended goals.
The AIA has managed to address many of the major differences between U.S. and European patent law.224 It has shifted
the United States from first-to-invent to first-to-file,225 it has

221. Leahy-Smith America Invents Act, Pub. L. No. 112-29, sec. 10, 125
Stat. 284, 316 (2011).
222. Id.
223. H.R. REP. NO. 112-98, at 38–40 (2011).
224. See Leahy-Smith America Invents Act, secs. 3, 6(a), 15.
225. Id. at sec. 3.
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dropped the “best mode” defense in validity litigation,226 and it
has instituted a post-grant review system modeled after the
European patent opposition.227 Yet the post-grant system established by AIA falls short of its intended goals to reduce validity litigation and strengthen issued patents. If the post-grant
review system is used at a significant rate, it will strengthen
patents because the increase in what issues can be raised and
the robust estoppel provisions will greatly reduce what can be
challenged in federal court. One may believe that because it is
so similar to the European system it would be used at a similar
rate (around five percent), and it may be used more frequently
because many of the issues with the old inter partes reexamination have been addressed (including what issues can be raised,
what evidence can be used, and the ability to settle prior to a
ruling from the BPAI). Because of the institutional differences
between the United States and Europe, however, it is unlikely
that there will be such a large increase in the use of the postgrant system in the United States. First, it is unnecessary to
invalidate a patent through the USPTO in order to avoid duplicative litigation.228 Second, the estoppel provisions, while
slightly countered by the lower evidence standard, tie the
hands of litigators when it comes to defending against infringement.229 Finally, due to Federal Rule of Civil Procedure
13(a), there is an institutional bias for counterclaims in patent
litigation.230 As a result, the post-grant process is unlikely to be
used at a significant rate, and as a result patents are unlikely
to be any stronger than before.
In order to increase the strength of issued patents, the patents must be stronger prior to entering the post-grant review
and litigation phase. The AIA takes a step in the right direction
by increasing what can be submitted by third parties prior to
issuance.231 In order to truly strengthen the issued patents,
226. Id. at sec. 15.
227. Id. at sec. 6(a).
228. See Parklane Hosiery Co. v. Shore, 439 U.S. 322, 327–28 (1979); Hoult
v. Hoult, 157 F.3d 29, 31–32 (1st Cir. 1998); Car Carriers, Inc. v. Ford Motor
Co., 789 F.2d 589, 595 (7th Cir. 1986).
229. See Parklane Hosiery Co., 439 U.S. at 327–28; Hoult, 157 F.3d at 31–
32; Car Carriers, Inc., 789 F.2d at 595.
230. See FED. R. CIV. P. 13(a); Polymer Indus. Prods. v. Bridgestone/Firestone, Inc., 347 F.3d 935, 938 (Fed. Cir. 2003); Akzona, Inc. v. E. I.
Du Pont de Nemours & Co., 662 F. Supp. 603, 618 (D. Del. 1987); Deering Milliken, Inc. v. Koratron Co., 293 F. Supp. 518, 522 (S.D.N.Y. 1968).
231. See Leahy-Smith America Invents Act, sec 8(a).
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however, the patent office must also increase the number of examiners and narrow claim construction. This will result in a
longer and more thorough patent application process, which
will increase strains on an already overburdened and inefficient system. However, if the overall goal is to reduce litigation
and increase patent strength, the changes are necessary.

